
Acorda Therapeutics ACOR
Quarterly report 2024-Q1
added 05-16-2026
Acorda Therapeutics Total Inventories 2011-2026 | ACOR
Annual Total Inventories Acorda Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.2 M | 12.8 M | 18.5 M | 28.7 M | 25.2 M | 29 M | 37.5 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 37.5 M | 12.8 M | 24 M |
Quarterly Total Inventories Acorda Therapeutics
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.1 M | 17.9 M | 14.8 M | 13.5 M | 12.8 M | 15.3 M | 15.3 M | 14.8 M | 18.5 M | 20.6 M | 25.4 M | 27.4 M | 28.7 M | 30.1 M | 32.9 M | 25.6 M | 25.2 M | 27.4 M | 28.1 M | 31.5 M | 29 M | 29 M | 29 M | 29 M | 37.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 37.5 M | 12.8 M | 23.7 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Happiness Biotech Group Limited
HAPP
|
653 K | - | 1.35 % | $ 17.8 M | ||
|
Esperion Therapeutics
ESPR
|
105 M | $ 3.13 | - | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
15.4 M | $ 32.59 | -6.89 % | $ 877 M | ||
|
Berkeley Lights
BLI
|
18.9 M | - | -7.31 % | $ 87 M | ||
|
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.7 | 3.03 % | $ 452 M | ||
|
Heron Therapeutics
HRTX
|
92.7 M | $ 0.86 | -1.42 % | $ 143 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
1.38 M | - | -4.36 % | $ 27 M | ||
|
Anika Therapeutics
ANIK
|
18.8 M | $ 14.88 | -0.93 % | $ 213 M | ||
|
Incyte Corporation
INCY
|
101 M | $ 97.16 | -0.26 % | $ 19 B | ||
|
Ionis Pharmaceuticals
IONS
|
10 M | $ 75.56 | -0.29 % | $ 12.1 B | ||
|
Coherus BioSciences
CHRS
|
3.17 M | $ 1.61 | 2.55 % | $ 189 M | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 20.86 | -0.71 % | $ 2.65 B |